MYRA MORALES: Open Payments
NPI 1063972578 · PLANTATION, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,425 in 158 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $2,444 · 2025 $3,425
Food & beverage: $3,425
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $514 |
| Axsome Therapeutics, Inc. | 16 | $422 |
| Otsuka America Pharmaceutical, Inc. | 12 | $403 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $399 |
| Janssen Pharmaceuticals, Inc | 19 | $358 |
| Neurocrine BioSciences, Inc. | 11 | $332 |
| E.R. Squibb & Sons, L.L.C. | 12 | $296 |
| Almatica Pharma LLC | 8 | $167 |
| Alkermes, Inc. | 5 | $93 |
| Braeburn Inc. | 5 | $92 |
Products named: VRAYLAR, CAPLYTA, Auvelity, REXULTI, INGREZZA, COBENFY, INVEGA SUSTENNA, LOREEV XR.
Industry payments across FL — which companies pay providers there.
